Compassionate use of remdesir and convalescent plasma therapy for the treatment of COVID-19 infection in Nepal: a prospective observational study
Executive Summary: Background As of December 2020, the COVID-19 pandemic has infected over 80 million people and caused over 1.7 million deaths worldwide. Over 250 thousand cases of infection and over 1800 deaths have occurred in Nepal. An approved antiviral therapy for the treatment of COVID-19 i...
Guardat en:
Autors principals: | Gyanwali, Pradeep, Bhattarai, Saroj, Dhimal, Meghnath |
---|---|
Format: | Technical Report |
Idioma: | en_US |
Publicat: |
Nepal Health Research Council
2021
|
Matèries: | |
Accés en línia: | http://103.69.126.140:8080/handle/123456789/743 |
Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|
Ítems similars
-
Assessment of health status of home isolated COVID-19 patients in Nepal
per: Gyanwali, Pradeep, et al.
Publicat: (2021) -
Assessment of status of post-recovery patients with COVID-19 infections in Nepal
per: Gyanwali, Pradeep, et al.
Publicat: (2021) -
Compassionate use of remdesir and convalescent plasma therapy for the treatment of COVID-19 infection in Nepal: a prospective observational study.
Publicat: (2021) -
Responding to COVID-19: health sector preparedness, response and lessons learnt
Publicat: (2021) -
Covid-19: Effect of lockdown on mental and physical health.
per: Gautam, Dikshya
Publicat: (2020)